TICEBA is a German biopharmaceutical company, highly specialized in high-throughput, off-the-shelf GMP-manufacturing of ABCB5-positive mesenchymal stem cells (ABCB5+ MSCs) as a drug (IND, ATMP), currently tested in several clinical trials by RHEACELL. TICEBA is active in the field of advanced stem cell research and regenerative medicine around ABCB5-positive MSCs with more than 15 years of expertise and exclusive access to the ABCB5-platform technology, IP and proprietary and patented production know how (H.F.M).